[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335170-105":59,"doc-detail-335170-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","combined-statistical-analysis-of-glioblastoma-outcomes-a-neurosurgical-single-institution-retrospective-study","Combined Statistical Analysis of Glioblastoma Outcomes - A Neurosurgical Single-Institution Retrospective Study","","Glioblastoma (GBM) remains the most aggressive primary brain malignancy, characterized by resistance to therapy and frequent tumoral recurrence despite major progress in cancer management. This retrospective neurosurgical single-institution study evaluated patients with histopathologically confirmed GBM treated between June 2011 and June 2023, analyzing clinical outcomes and relevant survival factors. Among 518 patients, women and men were analyzed alongside clinical manifestations and tumor locations.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/combined-statistical-analysis-of-glioblastoma-outcomes-a-neurosurgical-single-institution-retrospective-study/335170/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/combined-statistical-analysis-of-glioblastoma-outcomes-a-neurosurgical-single-institution-retrospective-study/335170.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why does glioblastoma have such poor outcomes?","Question",{"text":112,"@type":113},"GBM prognosis remains dismal due to treatment resistance and tumoral recurrence after neurosurgical excision.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What was the time range and study type of the research?",{"text":117,"@type":113},"The study retrospectively reviewed patients with confirmed GBM treated from June 2011 to June 2023 in a single neurosurgical department.",{"name":119,"@type":110,"acceptedAnswer":120},"Which factors were associated with prolonged survival?",{"text":121,"@type":113},"Survival was prolonged in patients younger than 60, those with gross total tumoral resection and less than 30% tumoral necrosis, and those who underwent adjuvant radiotherapy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335170,1790154554,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","medicina  \nArticle  \nCombined Statistical Analysis of Glioblastoma Outcomes—ANeurosurgical Single-Institution Retrospective Study  \nLigia Gabriela Tataranu 1,2, *, Georgiana Adeline Staicu 3, Anica Dricu 3, Serban Turliuc 4, Dan Paunescu 2, Amira Kamel 2 and Radu Eugen Rizea 1,2  \nCitation: Tataranu, L.G.; Staicu, G.A.; Dricu, A.; Turliuc, S.; Paunescu, D.; Kamel, A.; Rizea, R.E. Combined Statistical Analysis of Glioblastoma Outcomes—A Neurosurgical Single-Institution Retrospective Study. Medicina 2024, 60, 1234. [https://](https://)[ ](https://)[doi.org/10.3390/medicina60081234](doi.org/10.3390/medicina60081234)  \nAcademic Editor: Salvatore Chibbaro  \nReceived: 24 June 2024  \nRevised: 21 July 2024  \nAccepted: 28 July 2024  \nPublished: 30 July 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Neurosurgical Department, University of Medicine and Pharmacy “Carol Davila”,  \n020022 Bucharest, Romania; [rizea.radu.eugen@gmail.com](rizea.radu.eugen@gmail.com)  \n2 Neurosurgical Department, Clinical Emergency Hospital “Bagdasar-Arseni”, 041915 Bucharest, Romania; [cdpaunescu@yahoo.com](cdpaunescu@yahoo.com) (D.P.); [kamel.amyra@yahoo.com](kamel.amyra@yahoo.com) (A.K.)  \n3 Biochemistry Department, University of Medicine and Pharmacy, 200349 Craiova, Romania; [adstaicu@gmail.com](adstaicu@gmail.com) (G.A.S.); [anica.dricu@live.co.uk](anica.dricu@live.co.uk) (A.D.)  \n4 Medical Department, University of Medicine and Pharmacy “G. T. Popa”, 700115 Iasi, Romania; [serban_turliuc@yahoo.com](serban_turliuc@yahoo.com)  \n* Correspondence: [ligia.tataranu@umfcd.ro](ligia.tataranu@umfcd.ro)  \nAbstract: Background and Objectives: Notwithstanding the major progress in the management of cancerous diseases in the last few decades, glioblastoma (GBM) remains the most aggressive brain malignancy, with a dismal prognosis, mainly due to treatment resistance and tumoral recurrence. In order to diagnose this disease and establish the optimal therapeutic approach to it, a standard tissue biopsy or a liquid biopsy can be performed, although the latter is currently less common. To date, both tissue and liquid biopsy have yielded numerous biomarkers that predict the evolution and response to treatment in GBM. However, despite all such efforts, GBM has the shortest recorded survival rates of all the primary brain malignancies. Materials and Methods: We retrospectively reviewed patients with a confirmed histopathological diagnosis of glioblastoma between June 2011 and June 2023 . All the patients were treated in the Third Neurosurgical Department of the Clinical Emergency Hospital“Bagdasar-Arseni” in Bucharest, and their outcomes were analyzed and presented accordingly. Results: Out of 518 patients in our study, 222 (42.8%) were women and 296 (57.14%) were men. The most common clinical manifestations were headaches and limb paralysis, while the most frequent tumor locations were the frontal and temporal lobes. The survival rates were prolonged in patients younger than 60 years of age, in patients with gross total tumoral resection and less than 30% tumoral necrosis, as well as in those who underwent adjuvant radiotherapy. Conclusions: Despite significant advancements in relation to cancer diseases, GBM is still a field of great interest for research and in great need of new therapeutic approaches. Although the multimodal therapeutic approach can improve the prognosis, the survival rates are still short and the recurrences are constant.  \nKeywords: glioblastoma; neurosurgery; outcomes; survival rate; brain malignancy  \n1. Introduction  \nGlioblastoma (GBM) represents the most aggressive brain malignancy, and despite major recent advances in the managem","cbCairdxoqIAfwpV","https://ap.wps.com/l/cbCairdxoqIAfwpV","pdf",4945235,"English","# Introduction\n# Materials and Methods","[{\"question\":\"Why does glioblastoma have such poor outcomes?\",\"answer\":\"GBM prognosis remains dismal due to treatment resistance and tumoral recurrence after neurosurgical excision.\"},{\"question\":\"What was the time range and study type of the research?\",\"answer\":\"The study retrospectively reviewed patients with confirmed GBM treated from June 2011 to June 2023 in a single neurosurgical department.\"},{\"question\":\"Which factors were associated with prolonged survival?\",\"answer\":\"Survival was prolonged in patients younger than 60, those with gross total tumoral resection and less than 30% tumoral necrosis, and those who underwent adjuvant radiotherapy.\"}]","Combined Statistical Analysis of Glioblastoma Outcomes - A Neurosurgical Single-Institution Retrospective Study | PDF",1790009890,48]